Analysis

Commentary: A call for preventive ethics

BMJ 2009; 338 doi: https://doi.org/10.1136/bmj.b753 (Published 11 March 2009) Cite this as: BMJ 2009;338:b753
  1. Jeremy Sugarman, Harvey M Meyerhoff professor of bioethics and medicine
  1. 1Berman Institute of Bioethics and Department of Medicine, 624 N Broadway, Baltimore, MD 21205, USA
  1. jsugarm1{at}jhmi.edu

    The current practice of sending reduction mammoplasty specimens for routine histological examination can result in a complicated set of circumstances that raise important ethical issues. As described by Keshtgar and colleagues, a small but measurable subset of these specimens show malignancy of uncertain clinical significance.1 Since patients undergoing this reconstructive procedure apparently are not informed about screening of the tissue removed during surgery, they may be understandably surprised that cancer was found and also face …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe